MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-24-0002378
Elysium Pharmaceuticals Ltd - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹159.55 Cr
▼ 26% YoY
Net profit · FY 2024
₹18.35 Cr
Net margin 11.5%
EBITDA · FY 2024
₹37.66 Cr
EBITDA margin 23.6%
Authorised capital
₹22 Cr
Registered with MCA
Paid-up capital
₹16 Cr
Issued & subscribed
Open charges
₹81.05 Cr
Satisfied ₹165.22 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
337
Provident fund records
About Elysium Pharmaceuticals Ltd
Data last updated:
Elysium Pharmaceuticals Ltd is a public limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 January 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1995PLC024164. Its GSTIN is 24AABCE1232A1ZN (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹22 Cr and a paid-up capital of ₹16 Cr. It is led by directors including Yashwantrai Chunibhai Patel (Managing Director) and Jinkal Darshan Patel (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.1175 P.O. Dabhasa Tal. Padra, Vadodara, Gujarat, India – 391440.
As per the financials filed for FY 2024, the company reported a revenue of ₹159.55 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹18.35 Cr (net margin 11.5%) and EBITDA of ₹37.66 Cr (EBITDA margin 23.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 16% over five years.
The company has about 337 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Elysium Pharmaceuticals. As per MCA filings, the company has open charges of ₹81.05 Cr and satisfied charges of ₹165.22 Cr on record. Court records list 327 cases involving the company, including 262 filed by the company and 65 filed against it; 89 cases are pending. The company has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹5.6 Cr; the latest was in May 2016. Its 5 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Vivin Drugs & Pharmaceuticals Private Limited with revenue of ₹161.52 Cr. The company has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 33 overdue payments to 32 micro and small suppliers.
Elysium Pharmaceuticals Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0002378). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elysiumpharma.com.
Company details
CIN U24231GJ1995PLC024164
Registration Number 024164
Incorporation Date 11 January 1995
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-24-0002378
CIN history
Elysium Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231GJ1995PTC024164. The current CIN is U24231GJ1995PLC024164, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231GJ1995PLC024164 | Current |
| U24231GJ1995PTC024164 | Previous |
Key People
Yashwantrai Chunibhai Patel Managing Director Jinkal Darshan Patel Whole-Time Director Shitalkumar Navnitbhai Patel Whole-Time Director Recognitions & Rankings of Elysium Pharmaceuticals
Contact details
Elysium Pharmaceuticals Ltd's registered office is in Vadodara, Gujarat. Its website is elysiumpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.1175 P.O. Dabhasa Tal. Padra, Vadodara, Gujarat, India – 391440
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Elysium Pharmaceuticals Ltd, buy the company report.
Comprehensive company report
Elysium Pharmaceuticals Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Elysium Pharmaceuticals operates one associated brand: Elysium Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Heavy machinery components including gears and mill equipment are manufactured. | elysiumpharma.com |
Business activity
The main business activity of Elysium Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Elysium Pharmaceuticals Ltd, buy the company report.
Financials of Elysium Pharmaceuticals Ltd
FY 2024 filings availableElysium Pharmaceuticals Ltd reported revenue of ₹159.55 Cr (down 26% YoY) for FY 2024.
Revenue · FY 2024
₹159.55 Cr ▼ 26%
Net profit · FY 2024
₹18.35 Cr margin 11.5%
EBITDA · FY 2024
₹37.66 Cr margin 23.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 26%
3 years · compounded
▼ 1%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▼ 35%
3 years · compounded
▼ 8%
5 years · compounded
▲ 16%
Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.35 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.6% | ||||
| Net Profit Margin | 11.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elysium Pharmaceuticals Ltd, buy the company report.
Board of directors of Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals has 7 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vithalbhai Shankerbhai Patel | Director | 21 Jun 2006 | 20 Years 4 Months | Current |
| Hiren Prakash Barot Also directs: Barot & Barot Developers LLP | Additional Director | 17 Feb 2025 | 1 Years 8 Months | Current |
| Jinkal Darshan Patel Also directs: Atlanta Electricals Limited | Whole-Time Director | 30 Jan 2020 | 6 Years 8 Months | Current |
| Chandani Ankitkumar Jhanwar Also directs: Rama Polycon Limited, Ratnadeep Metal and Tubes Limited | Director | 17 Feb 2023 | 3 Years 8 Months | Current |
| Shitalkumar Navnitbhai Patel | Whole-Time Director | 30 Jan 2020 | 6 Years 8 Months | Current |
| Yashwantrai Chunibhai Patel | Managing Director | 25 Sep 2015 | 11 Years 1 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Elysium Pharmaceuticals Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vivin Drugs & Pharmaceuticals Private Limited | ₹161.52 Cr (FY 2023) | -25.0% | Hyderabad, Telangana, India | |||
| Laboratoires Griffon Private Limited | ₹161.12 Cr (FY 2024) | 8.0% | Kolkata, West Bengal, India | |||
| Elysium Pharmaceuticals Ltdthis company | ₹159.55 Cr (FY 2024) | ₹18.35 Cr | 11.5% | -26.0% | 337 | Vadodara, Gujarat, India |
| VHB Medi Sciences Limited | ₹159.28 Cr (FY 2025) | 14.0% | Kandivlai West, Maharashtra, India | |||
| Jenburkt Pharmaceuticals Ltd | ₹158.41 Cr (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Wardex Pharmaceuticals Private Limited | ₹158.1 Cr (FY 2025) | 8.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Elysium Pharmaceuticals Ltd, buy the company report.
Auditor
Elysium Pharmaceuticals Ltd is audited by O. P. RATHI & CO. for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| O. P. RATHI & CO. | FY 2021 | 108718W |
Shareholding
The shareholding of Elysium Pharmaceuticals Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Elysium Pharmaceuticals Ltd, buy the company report.
Charges & borrowings
Open charges
₹81.05 Cr
Satisfied charges
₹165.22 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Mar 2022 | 100568074 | Others | ₹18.43 Cr | Open | |
| 04 Jul 2014 | 10508871 | Others | ₹31.31 Cr | Open | |
| 11 Dec 2010 | 10257659 | Others | ₹31.31 Cr | Open | |
| 15 Mar 2022 | 100558391 | Others | ₹2.29 Cr | Satisfied | |
| 27 Oct 2021 | 100492834 | Others | ₹26 Cr | Satisfied |
To see the full charge records of Elysium Pharmaceuticals Ltd, buy the company report.
Total charge records: 18 View all charges
Deals & funding
Elysium Pharmaceuticals Ltd has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹5.6 Cr; the latest was in May 2016.
Total deals
4
Funding rounds
3
Rights issue
1
Disclosed funding
₹5.6 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2016 | Rights issue | ₹2 Cr | Investors: an individual |
| Jul 2010 | Funding round | ₹19.7 Lakh | Investors: 4 individuals |
| Apr 2007 | Funding round | ₹1.11 Cr | Investors: Others - Elysium Pharmaceuticals Limited, 3 individuals |
| Aug 2006 | Funding round | ₹4.29 Cr | Investors: Others - Elysium Pharmaceuticals Limited, 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Elysium Pharmaceuticals Ltd has 327 court cases on record: 262 filed by Elysium Pharmaceuticals, 65 filed against it. 89 cases are pending and 238 are disposed.
Total cases
327
Filed by the company
262
Filed against the company
65
Pending
89
Disposed
238
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 250 | 50 | 32 |
| High courts | 77 | 15 | 57 |
Cases on record (5 of 327)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Court case (RECO33C2-LC) | Filed against the company by an individual | Pending |
| District court, Vadodara, Gujarat | Court case (RECO33C2-LC) | Filed against the company by an individual | Pending |
| District court, Vadodara, Gujarat | Court case (RECO33C2-LC) | Filed against the company by an individual | Pending |
| District court, Vadodara, Gujarat | Court case (RECO33C2-LC) | Filed against the company by an individual | Pending |
| District court, Vadodara, Gujarat | Court case (RECO33C2-LC) | Filed against the company by an individual | Pending |
To see the full case history of Elysium Pharmaceuticals Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Elysium Pharmaceuticals Ltd was last rated by Brickwork on 31 May 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Brickwork | 31 May 2021 |
To see the full credit ratings and regulatory alerts of Elysium Pharmaceuticals Ltd, buy the company report.
MSME payment delays
Elysium Pharmaceuticals Ltd has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 33 overdue payments to 32 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 32)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| H. B. Chemicals | |||
| Absolute Filtertech | |||
| Aadarsh Enterprise |
To see the full MSME payment records of Elysium Pharmaceuticals Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Elysium Pharmaceuticals Ltd has a workforce of 337 employees on its EPFO records as of Mar 03, 2025, across 1 active EPFO establishment.
Employee count
337
Active EPFO establishments
1
Employee growth
-3.99%
GST
Elysium Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCE1232A1ZN | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Elysium Pharmaceuticals Ltd, buy the company report.
Recent activity
Elysium Pharmaceuticals Ltd has 17 board changes on record since 2006: 7 appointments and 10 cessations. The latest: Hiren Prakash Barot was appointed as Additional Director on 17 Feb 2025.
Charges
A charge registered on 31 Aug 2021 via Charge ID 100483450 with Others was fully satisfied on 07 Aug 2025.
Charges
A charge with Others of Rs. 31.31 Cr registered on 04 Jul 2014 with Charge ID 10508871 was modified on 07 Aug 2025.
Charges
A charge registered on 15 Feb 2014 via Charge ID 10480281 with State Bank Of India was fully satisfied on 07 Aug 2025.
Charges
A charge with Others of Rs. 31.31 Cr registered on 11 Dec 2010 with Charge ID 10257659 was modified on 07 Aug 2025.
Charges
A charge registered on 16 Feb 2010 via Charge ID 10209989 with State Bank Of India was fully satisfied on 07 Aug 2025.
Charges
A charge registered on 03 Jul 2002 via Charge ID 80047401 with State Bank Of India was fully satisfied on 07 Aug 2025.
Charges
A charge registered on 18 Jan 2002 via Charge ID 90103268 with State Bank Of India - Lead Bank was fully satisfied on 07 Aug 2025.
Charges
A charge registered on 15 Mar 2022 via Charge ID 100558391 with Others was fully satisfied on 06 Aug 2025.
Charges
A charge with Others of Rs. 18.43 Cr registered on 11 Mar 2022 with Charge ID 100568074 was modified on 06 Aug 2025.
Charges
A charge registered on 05 Mar 2020 via Charge ID 100332628 with Others was fully satisfied on 06 Aug 2025.
Charges
A charge registered on 27 Oct 2021 via Charge ID 100492834 with Others was fully satisfied on 06 Jun 2025.
Appointed
Hiren Prakash Barot was appointed as Additional Director.
52 earlier events are in the company report.
Frequently asked questions
Elysium Pharmaceuticals is an active public limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 January 1995 (31+ years old) and is registered under CIN U24231GJ1995PLC024164.
Elysium Pharmaceuticals has 7 current directors:
- Yashwantrai Chunibhai Patel - Managing Director
- Jinkal Darshan Patel - Whole-Time Director
- Shitalkumar Navnitbhai Patel - Whole-Time Director
- Suhasini Rajnikant Patel - Whole-Time Director
- Vithalbhai Shankerbhai Patel - Director
- Hiren Prakash Barot - Additional Director
- Chandani Ankitkumar Jhanwar - Director
The latest financial statements of Elysium Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Elysium Pharmaceuticals is 24AABCE1232A1ZN, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Elysium Pharmaceuticals is U24231GJ1995PLC024164. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elysium Pharmaceuticals has 327 court cases on record: 262 filed by the company and 65 filed against it. 89 are pending. Most are in the district courts.
Elysium Pharmaceuticals was incorporated on 11 January 1995, making it 31+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Elysium Pharmaceuticals has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹5.6 Cr; the latest was in May 2016.
The peers of Elysium Pharmaceuticals by revenue are Vivin Drugs & Pharmaceuticals Private Limited, Laboratoires Griffon Private Limited, VHB Medi Sciences Limited, Jenburkt Pharmaceuticals Ltd, Wardex Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hiren Prakash Barot was appointed as Additional Director on 17 Feb 2025. Chandani Ankitkumar Jhanwar was appointed as Director on 17 Feb 2023. Bharatkumar Rameshchandra Desai ceased to be Director on 24 Jan 2023. Elysium Pharmaceuticals has 17 board changes on record in total.
Yes, Elysium Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-24-0002378).
Elysium Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 33 overdue payments to 32 micro and small suppliers. The latest return was filed on 08 Jun 2019.